Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HYPERTHERMIA
Volume 32, Issue 1, Pages 89-95
Publisher
Informa UK Limited
Online
2016-01-25
DOI
10.3109/02656736.2015.1119317
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
- (2015) A Laroche-Clary et al. BRITISH JOURNAL OF CANCER
- Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review
- (2014) Imen Belhadj Slimen et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Local tumour hyperthermia as immunotherapy for metastatic cancer
- (2014) Seiko Toraya-Brown et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
- (2013) S. Rusakiewicz et al. CANCER RESEARCH
- Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
- (2013) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies
- (2012) Berina Eppink et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma
- (2011) Antoine Italiano et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Anticancer effects of imatinib via immunostimulation
- (2011) Laurence Zitvogel et al. NATURE MEDICINE
- Homologous recombination research is heating up and ready for therapy
- (2011) S. N. Powell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
- (2011) P. M. Krawczyk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quality assurance for clinical studies in regional deep hyperthermia
- (2011) Gregor Bruggmoser et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
- (2010) Rolf D Issels et al. LANCET ONCOLOGY
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Hyperthermia adds to chemotherapy
- (2008) Rolf D. Issels EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now